甲基泼尼松龙联合红霉素治疗支原体感染后大叶性肺炎的效果观察  

Effects observation of Methylprednisolone combined with Erythromycin on lobar pneumonia after Mycoplasma infection

作　　者：彭俊娟[1] 季海娟[1] 朱玮[1] 

机构地区：[1]江苏省镇江市第一人民医院儿科,江苏镇江212000

出　　处：《中国当代医药》2016年第28期114-116,共3页China Modern Medicine

摘　　要：目的观察甲基泼尼松龙联合红霉素治疗支原体感染后大叶性肺炎的效果。方法 选择镇江市第一人民医院2014年5-11月收治的50例支原体肺炎患儿。将其分为观察组24例,对照组26例。对照组在地塞米松辅助红霉素静脉治疗基础上,予以常规止咳化痰对症处理。观察组应用甲基泼尼松龙辅助红霉素疗法。比较两组治疗效果。结果 观察组总有效率为100.0%,高于对照组的88.5%,差异有统计学意义（P〈0.05）。结论 甲基泼尼松龙联合红霉素治疗支原体感染后大叶性肺炎的效果肯定,用药安全,值得临床推广。Objective To observe the treatment effect of Methylprednisolone combined with Erythromycin on lobar pneumonia after Mycoplasma infection.Methods From May to November 2014,in the First People＇s Hospital of Zhen- Jiang,50 cases of Mycoplasma pneumonia children were selected and divided into treatment group （24 cases） and con- trol group （26 cases）.The control group was treated with Erythromycin and Intravenous dexamethasone therapy adding regular cough phlegm.Treatment group was treated with Erythromycin plus Methylprednisolone therapy.The treatment effect of the two groups was compared.Results The total effective rate of treatment group was 100.0% ,higher than 88.5% in the control group,with statistical difference （P〈0.05）.Conclusion The curative effect of Methylprednisolone combined with Erythromycin on lobar pneumonia after Mycoplasma infection is valuable,in the aspect of drug use is safe and is worthy to promote in clinical using.

关 键 词：甲基泼尼松龙 红霉素 儿童 支原体肺炎 

分 类 号：R375.2[医药卫生—病原生物学]